Skip to main content
New Medications
resource center
Menu
Menu
Main navigation
Home
Featured Diseases & Conditions
COVID-19
Depression Care 360
HIV Management
HIV Prevention
Pediatric Influenza
Psoriatic Arthritis
Resources
Commentary
Disease State Directory
FDA Alerts
Pearls
Podcasts
Polls
Q&As
Quizzes
Research Summaries
Slideshows
Videos
Events & Education
Consultant360's Practical Updates in Primary Care
CME
Publication
About Consultant
Consultant Current Issue
Consultant Early View
Consultant Archive
Author Guidelines
Case Report Templates
FAQ
Advertising With Consultant360
Search
Login
Menu
Menu
Main navigation
Home
Featured Diseases & Conditions
COVID-19
Depression Care 360
HIV Management
HIV Prevention
Pediatric Influenza
Psoriatic Arthritis
Resources
Commentary
Disease State Directory
FDA Alerts
Pearls
Podcasts
Polls
Q&As
Quizzes
Research Summaries
Slideshows
Videos
Events & Education
Consultant360's Practical Updates in Primary Care
CME
Publication
About Consultant
Consultant Current Issue
Consultant Early View
Consultant Archive
Author Guidelines
Case Report Templates
FAQ
Advertising With Consultant360
New Medications
Resource Center
News
Research Summaries
Resources
FDA Alerts
Pearls of Wisdom
From the Journal
Insights
Commentary
Podcasts
Q&As
Videos
Interactive
Polls
Quizzes
Slideshows
Events & Education
FDA Alerts
Severe Asthma
Severe Asthma
FDA Approves First Combination Inhaled Corticosteroid for Asthma
01/27/2023
01/27/2023
Treatment
Treatment
FDA Accelerates Approval for New Alzheimer Treatment
01/10/2023
01/10/2023
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis
FDA Approves New Medication for Treatment of ALS
10/07/2022
10/07/2022
Medication
Medication
FDA Approves First Treatment for Acid Sphingomyelinase Deficiency
09/20/2022
09/20/2022
Treatment
Treatment
FDA Approves First Treatment for Active Psoriatic Arthritis in Pediatric Patients
08/23/2022
08/23/2022
new medications
new medications
FDA Approved New Treatment for Heavy Menstrual Bleeding Caused by Uterine Fibroids
05/29/2020
The approval comes after results from 2 phase 3 trials showed that the medication significantly reduced the amount of heavy bleeding compared with placebo.
05/29/2020